Literature DB >> 21468773

Changes in expression of proteoglycan core proteins and heparan sulfate enzymes in the developing and adult murine aorta.

Neeta Adhikari1, Marjorie Carlson, Ben Lerman, Jennifer L Hall.   

Abstract

Proteoglycan core proteins are linked to four different classes of linear sugar chains referred to as glycosaminoglycans. Heparan sulfate constitutes one of these classes of glycosaminoglycans, and has been shown to be important in developmental processes as well as disease. We designed a low-density gene expression array to identify expression levels of heparan sulfate biosynthetic enzymes and proteoglycan core proteins in the aorta of late stage embryos (E18.5) and adult mice (12 weeks). Significant changes were found in mRNA expression of proteoglycan core proteins syndecan, glypican, decorin, perlecan, and versican from development to adulthood (n = 8, p < 0.05). Immunohistochemistry revealed a striking localization of both decorin and perlecan staining to the subendothelium in adult vessels, which differed from consistent staining of the endothelium, smooth muscle, and adventitia in development. Significant differences were also identified in the expression of the heparan sulfate modifying enzymes, glururonyl C5 epimerase, 2-O and 6-O sulfotransferases, and N-deacetylase/N sulfotransferases 1-3 (n = 8, p < 0.05). In conclusion, proteoglycan core proteins and heparan sulfate biosynthetic enzymes in the aorta undergo significant changes in their expression from development to adulthood. These findings may have important biological significance in the specific cell-defined roles of proteoglycan and heparan sulfate related targets in vascular development, maintenance, and response to various perturbations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21468773      PMCID: PMC4066468          DOI: 10.1007/s12265-011-9261-7

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  48 in total

1.  Tissue concentration of heparin, not administered dose, correlates with the biological response of injured arteries in vivo.

Authors:  M A Lovich; E R Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

Review 2.  Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?

Authors:  R D Rosenberg; N W Shworak; J Liu; J J Schwartz; L Zhang
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

3.  Suppression by heparin of smooth muscle cell proliferation in injured arteries.

Authors:  A W Clowes; M J Karnowsky
Journal:  Nature       Date:  1977-02-17       Impact factor: 49.962

4.  Versican expression is associated with chamber specification, septation, and valvulogenesis in the developing mouse heart.

Authors:  D J Henderson; A J Copp
Journal:  Circ Res       Date:  1998-09-07       Impact factor: 17.367

5.  Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor.

Authors:  V Lindner; M A Reidy
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

6.  Atherosclerosis in perlecan heterozygous mice.

Authors:  Reeba K Vikramadithyan; Yuko Kako; Guangping Chen; Yunying Hu; Eri Arikawa-Hirasawa; Yoshihiko Yamada; Ira J Goldberg
Journal:  J Lipid Res       Date:  2004-07-16       Impact factor: 5.922

7.  Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration.

Authors:  C Rogers; M J Karnovsky; E R Edelman
Journal:  Circulation       Date:  1993-09       Impact factor: 29.690

8.  Localization of proteoheparan sulfate in rat aorta.

Authors:  A W Clowes; M M Clowes; A M Gown; T N Wight
Journal:  Histochemistry       Date:  1984

9.  Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase.

Authors:  S L Bullock; J M Fletcher; R S Beddington; V A Wilson
Journal:  Genes Dev       Date:  1998-06-15       Impact factor: 11.361

10.  The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation.

Authors:  C H Mjaatvedt; H Yamamura; A A Capehart; D Turner; R R Markwald
Journal:  Dev Biol       Date:  1998-10-01       Impact factor: 3.582

View more
  9 in total

1.  Study of the development of the mouse thoracic aorta three-dimensional macromolecular structure using two-photon microscopy.

Authors:  Leah M Zadrozny; Edward B Neufeld; Bertrand M Lucotte; Patricia S Connelly; Zu-Xi Yu; Lam Dao; Li-Yueh Hsu; Robert S Balaban
Journal:  J Histochem Cytochem       Date:  2014-10-31       Impact factor: 2.479

Review 2.  Review and Updates in Regenerative and Personalized Medicine, Preclinical Animal Models, and Clinical Care in Cardiovascular Medicine.

Authors:  Emanuele Barbato; Paul J Barton; Jozef Bartunek; Sally Huber; Borja Ibanez; Daniel P Judge; Enrique Lara-Pezzi; Craig M Stolen; Angela Taylor; Jennifer L Hall
Journal:  J Cardiovasc Transl Res       Date:  2015-10-09       Impact factor: 4.132

3.  Dynamics of connective-tissue localization during chronic Borrelia burgdorferi infection.

Authors:  Denise M Imai; Sunlian Feng; Emir Hodzic; Stephen W Barthold
Journal:  Lab Invest       Date:  2013-06-24       Impact factor: 5.662

Review 4.  Aggrecan in Cardiovascular Development and Disease.

Authors:  Christopher D Koch; Chan Mi Lee; Suneel S Apte
Journal:  J Histochem Cytochem       Date:  2020-09-01       Impact factor: 2.479

Review 5.  Syndecan-1 in Cancer: Implications for Cell Signaling, Differentiation, and Prognostication.

Authors:  Tünde Szatmári; Rita Ötvös; Anders Hjerpe; Katalin Dobra
Journal:  Dis Markers       Date:  2015-09-01       Impact factor: 3.434

6.  Heparanase and Syndecan-4 Are Involved in Low Molecular Weight Fucoidan-Induced Angiogenesis.

Authors:  Oualid Haddad; Erwan Guyot; Nicolas Marinval; Fabien Chevalier; Loïc Maillard; Latifa Gadi; Christelle Laguillier-Morizot; Olivier Oudar; Angela Sutton; Nathalie Charnaux; Hanna Hlawaty
Journal:  Mar Drugs       Date:  2015-10-28       Impact factor: 5.118

Review 7.  Syndecan-1-coating of interleukin-17-producing natural killer T cells provides a specific method for their visualization and analysis.

Authors:  Anil Kumar Jaiswal; Mohanraj Sadasivam; Abdel Rahim A Hamad
Journal:  World J Diabetes       Date:  2017-04-15

8.  Glycosaminoglycan overproduction in the aorta increases aortic calcification in murine chronic kidney disease.

Authors:  Eko Purnomo; Noriaki Emoto; Dwi Aris Agung Nugrahaningsih; Kazuhiko Nakayama; Keiko Yagi; Susi Heiden; Satomi Nadanaka; Hiroshi Kitagawa; Ken-Ichi Hirata
Journal:  J Am Heart Assoc       Date:  2013-08-28       Impact factor: 5.501

9.  The matrix proteins aggrecan and fibulin-1 play a key role in determining aortic stiffness.

Authors:  Raya Al Maskari; Carmel M McEniery; Sarah E Cleary; Ye Li; Keith Siew; Nichola L Figg; Ashraf W Khir; John R Cockcroft; Ian B Wilkinson; Kevin M O'Shaughnessy
Journal:  Sci Rep       Date:  2018-06-04       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.